Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Feb 2026 for Bionano Genomics, Inc., €47. Read the official filing
Filing timeline
BuySaleR. Erik Holmlin
Insider track record
Disclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-43.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
R. Erik Holmlin: trading record in brief
R. Erik Holmlin is a declared insider of Bionano Genomics, Inc. (chief executive), with filings sourced from SEC (Form 4). The record holds 12 filings, for trades running from 12 May 2021 to 17 February 2026.
Purchases make up the whole of the open-market record (2 purchases, €17k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 10 share grants.
On 18 February 2026 came the latest disclosure, a share grant for €47 in Bionano Genomics, Inc. The clock since the last published purchase (16 May 2023) now reads 1,251 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to R. Erik Holmlin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
51 shares@ US$1.100.0% of flowCommon StockSEC:0001579988-26-000004:0
75 shares@ US$3.690.2% of flowCommon StockSEC:0001411690-25-000053:0
198 shares@ US$3.470.5% of flowCommon StockSEC:0001411690-25-000028:0
51 shares@ US$5.730.2% of flowCommon StockSEC:0001411690-25-000017:0
44,000 shares0Common StockSEC:0001415889-24-015621:0
3,073 shares@ US$1.272.9% of flowCommon StockSEC:0001415889-24-006809:0
15,000 shares@ US$0.64267.0% of flowCommon StockSEC:0001411690-23-000032:0
Canonical exit: 14 Aug 2023 (T+90)
50,141 shares@ US$0.6623.8% of flowCommon StockSEC:0001411690-23-000029:0
300,000 shares0Common StockSEC:0001209191-23-010921:0
50,141 shares@ US$1.410.41% mcap81.4% of flowCommon StockSEC:0001209191-22-029457:0
2,200 shares@ US$3.9856.5% of flowCommon StockSEC:0001209191-21-067229:0
Canonical exit: 27 Feb 2022 (T+90)
290,000 shares0Common StockSEC:0001209191-21-032934:0
12 of 12 declarations
